The peroxisome proliferator-activated receptor gamma (PPARγ) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness.
PLoS One
; 15(11): e0242427, 2020.
Article
in En
| MEDLINE
| ID: mdl-33186383
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Persian Gulf Syndrome
/
Rosiglitazone
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United States